GLP-1 / glucagon dual agonist · Altimmune
Track your Pemvidutide journey with Phaze
GLP-1 / glucagon dual agonist, tracked in one calm app.
Pemvidutide, Investigational, not yet FDA approved.
Phaze is a wellness and habit-tracking app. It is not a medical device and does not provide medical advice, diagnosis, or treatment. Pemvidutide is investigational and not FDA-approved as of 2026; Phaze does not supply, prescribe, or recommend any medication. Estimated medication levels are based on published pharmacokinetic data for informational purposes only. Always follow your healthcare provider's guidance.
Pemvidutide is a GLP-1 / glucagon dual agonist from Altimmune. Phaze is a wellness and habit-tracking app, not a medical device, that gives Pemvidutide users dose tracking, Estimated Levels, side-effect intelligence, labs, and progress in one private place.
Drug class
GLP-1 / glucagon dual agonist
Manufacturer
Altimmune
Status
Investigational
Route
Injectable
Dose tracking, dialed in
Schedule, log, and visualize every Pemvidutide dose. Injection-site rotation, prep checklist, dose calendar, and reminders that fit your plan. Dose tracking is free.
Labs & Scans
Track lab work across 8 categories (GLP-1, metabolic, lipids, vitamins, kidney, liver, thyroid, inflammation). Manual entry is free; OCR lab-document import is part of Phaze Pro. For information only, not medical advice.
Body Composition (Beta)
See your weight trend with dose markers, BMI over time, and an AI photo estimate of body fat % and muscle (±3–5%, with a confidence level). Body Composition is in Beta and lives inside Labs & Scans.
Side effects & check-ins
Log nausea, fatigue, and 15+ side effects with severity, then see trends like "Nausea is decreasing." Daily check-ins capture mood, energy, hunger, sleep, and bowel health.
Apple Watch & Estimated Levels
Estimated Levels shows your Pemvidutide building, peaking, and tapering across the dose cycle, based on published Phase 3 clinical trial data. It is free. Phaze also includes an Apple Watch app, widgets, and Live Activities.
Pemvidutide FAQ
Pemvidutide is a GLP-1 / glucagon dual agonist from Altimmune. As of 2026 it is investigational and not FDA-approved. Phaze is a tracking tool, not a source or supplier. This is general information, not medical advice. Talk to your doctor.
Phaze supports Pemvidutide dose scheduling, injection-site rotation, a prep checklist, a dose calendar, and reminders. Estimated Levels shows where you are in your dose cycle. Dose tracking and Estimated Levels are free.
No. As of 2026, Pemvidutide is investigational and not FDA-approved. Phaze does not supply, prescribe, or recommend any medication, and never claims approval that does not exist. Always confirm regulatory status with your healthcare provider. This is general information, not medical advice.
It estimates how the medication builds, peaks, and tapers across your dose cycle, based on published Phase 3 clinical trial data. It is for information only, not medical advice. Always follow your healthcare provider's guidance.
Phaze is purpose-built for GLP-1 users: dose tracking, Estimated Levels, side-effect intelligence, Labs & Scans, protein-first nutrition, an Apple Watch app, and local-first privacy. Medical data is encrypted with AES-256-GCM in the Apple Keychain.
Track Pemvidutide the calm way.
Doses, labs, body, and meals, in one private app. Free to start.
Download Phaze FreePhaze is a wellness and habit-tracking app. It is not a medical device and does not provide medical advice, diagnosis, or treatment. Pemvidutide is investigational and not FDA-approved as of 2026; Phaze does not supply, prescribe, or recommend any medication. Estimated medication levels are based on published pharmacokinetic data for informational purposes only. Always follow your healthcare provider's guidance.